Brief: Prime Medicine Prices Public Offering At $3.30 Per Share
31/07/2025 02:34
July 30 (Reuters) - Prime Medicine Inc PRME.O: PRIME MEDICINE ANNOUNCES PRICING OF PUBLIC OFFERING PRIME MEDICINE INC - PRICES PUBLIC OFFERING AT $3.30 PER SHARE Source text: ID:nGNX6HNXsm Further company coverage: PRME.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease